Ionic Rare Earths (ASX: IXR) Advances Magnet Recycling and REE Projects
Ionic Rare Earths (ASX: IXR) reports significant progress in magnet recycling and heavy rare earth projects, reducing CO₂ emissions.
Category: Materials
Duxton Farms (ASX:DBF) Announces Strategic Acquisitions and Asset Sales in Q3 FY2025
Duxton Farms (ASX:DBF) reports Q3 FY2025 activities, including strategic land acquisitions and significant asset sales to support growth and shareholder returns.
GreenTech Metals (ASX:GRE) Announces Q1 2025 Copper Drilling and Lithium Joint Venture
GreenTech Metals (ASX:GRE) reports significant copper drill results and a joint venture with Artemis to expand lithium projects in West Pilbara.
Mont Royal Resources (ASX:MRZ) Announces Merger with Commerce Resources
Mont Royal Resources (ASX:MRZ) merges with Commerce Resources to form a Canadian-focused critical metals company, enhancing its asset portfolio.
Patronus Resources (ASX: PTN) Enhances Mertondale Resource and Acquires Strategic Stakes
Patronus Resources (ASX: PTN) reports increased mineral resources and strategic investments in Q1 2025.
New Frontier Minerals (ASX:NFM) Reports Q1 2025 Highlights and Strategic Partnerships
New Frontier Minerals (ASX:NFM) reports Q1 2025 achievements, including exploration milestones, strategic alliance with Austral Resources, and asset sales.
Australian Rare Earths Limited (ASX:AR3) Completes $3.6M Rights Issue
Australian Rare Earths Limited (ASX:AR3) completes a $3.6M rights issue, enhancing project development and strategic positioning.
Rimfire Pacific Mining (ASX:RIM) Reports Q1 Drilling Success and Raises $3.65M
Rimfire Pacific Mining (ASX:RIM) announces successful Q1 scandium drilling at Murga and Currajong, and raises $3.65M in funding.
Odyssey Gold Limited (ASX:ODY) Commences Technical Study for Tuckanarra Project
Odyssey Gold Limited (ASX:ODY) has launched a Technical Study to evaluate mining and processing options for its Tuckanarra Gold Project.
Immutep Limited (ASX:IMM) Reports Q3 FY25 Milestones and Financial Position
Immutep Limited (ASX:IMM) announces significant clinical trial milestones and maintains a robust cash position in its Q3 FY25 report.